12:00 AM
 | 
Jan 09, 2012
 |  BC Week In Review  |  Company News  |  Deals

Supernus deal

Neurology company Supernus raised $42 million in December. The amount comprises $15 million in venture debt and $27 million from the sale of its TCD Royalty LLC subsidiary to Royalty Opportunities S.a.r.l., an affiliate of OrbiMed...

Read the full 160 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >